Sort
50,496 grants matching “lung cancer”
Roles and regulation of transcriptional reprogramming in squamous carcinogenesis
$468,096Markus Schober · New York University School Of Medicine · R01 · FY2024 · CA
Semiparametric Analysis of Big Censored Data
$467,993Danyu Lin · Univ Of North Carolina Chapel Hill · R01 · FY2020 · HL
Metabolic activation of nitroarenes and Nrf2-Keap1
$467,978Trevor M. Penning · University Of Pennsylvania · R01 · FY2020 · ES
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy
$467,825James K Turkson · University Of Hawaii At Manoa · R01 · FY2014 · CA
MEK AND PI3K INHIBITION IN THE REGULATION OF PANCREATIC CANCER METABOLISM
$467,774Lewis C Cantley · University Of Tx Md Anderson Can Ctr · P01 · FY2015 · CA
Targeting apoptotic caspases to enhance cancer radiotherapy
$467,757Chuan-Yuan Li · Duke University · R01 · FY2021 · CA
Targeting apoptotic caspases to enhance cancer radiotherapy
$467,757Chuan-Yuan Li · Duke University · R01 · FY2020 · CA
Regulation of Tumor Metastasis by E-Cadherin Activation and Hippo Signaling
$467,754Barry M Gumbiner · Seattle Children'S Hospital · R01 · FY2018 · CA
Regulation of Tumor Metastasis by E-Cadherin Activation and Hippo Signaling
$467,754Barry M Gumbiner · Seattle Children'S Hospital · R01 · FY2020 · CA
Regulation of Tumor Metastasis by E-Cadherin Activation and Hippo Signaling
$467,754Barry M Gumbiner · Seattle Children'S Hospital · R01 · FY2017 · CA
Regulation of Tumor Metastasis by E-Cadherin Activation and Hippo Signaling
$467,754Barry M Gumbiner · Seattle Children'S Hospital · R01 · FY2016 · CA
Real Time, Automated Singlet Oxygen Dosimeter for PDT
$467,661Steven J Davis · Physical Sciences, Inc · R44 · FY2008 · CA
Atlases to Report and Correlate Radiotherapy Dose Distributions with Outcomes
$467,645Andrew Jackson · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA
Moffitt Imaging Biomarker VAlidation Center
$467,624Matthew B. Schabath · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2021 · CA
Use of metformin in the treatment of thyroid cancer
$467,612Joanna Klubo-Gwiezdzinska · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Application of molecular diagnostics in thyroid cancer
$467,612Joanna Klubo-Gwiezdzinska · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
TRIM37 is a genetic determinant of racial disparity in metastatic TNBC patients
$467,606Sanchita Bhatnagar · University Of California At Davis · R01 · FY2023 · CA
Role of T regulatory suppression in autoimmunity and cancer
$467,606Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Measuring extracellular pH in pre-clinical tumor models with CEST MRI
$467,603Mark David Pagel · University Of Arizona · R01 · FY2012 · CA
A pro-metastatic secretory pathway activated by p53 loss in lung cancer
$467,592Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Mechanism of Intratumoral Transport of Particulate Drugs
$467,591Haifa Shen · Methodist Hospital Research Institute · R01 · FY2018 · CA
Diagnosis of Cancer in the Emergency Room - Explaining Persistent Disparities
$467,569Caroline Avery Thompson · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Mechanisms of STING in malignant progression and therapy of CLL.
$467,536Chih-Chi Andrew Hu · Methodist Hospital Research Institute · R01 · FY2024 · CA
Function of the CHRNA5 D398N SNP: implications for addiction and lung cancer ris
$467,458Jerry A Stitzel · University Of Colorado · R21 · FY2009 · DA
Targeting vulnerabilities in copper metabolism in the development of cancer therapies
$467,441Michael J Petris · University Of Missouri-Columbia · R01 · FY2021 · CA